SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: freelyhovering who wrote (813)11/16/1998 8:52:00 PM
From: betty blank  Read Replies (1) | Respond to of 998
 
Is this company making a net profit?

What does this drug do? And what is the chance of the approval?



To: freelyhovering who wrote (813)11/19/1998 12:41:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 998
 
Myron:

I don't follow them, so I asked a friend, Shahram Mori. He said that he likes modafinil, but that he's worried about timing of good news on that front relative to potential bad news with myo.

In general.... I'm not very good with companies that have either lost momentum or that have lost leverage. I don't go back and revisit stuff enough.

Sorry I couldn't be of more help.

Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News